CUSIP No. 028910107 Page 1 of 8 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
SCHEDULE 13G
Information Statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)
American Oncology Resources, Inc.
_________________________________________________________________
(Name of Issuer)
Common Stock, $.01 par value
_________________________________________________________________
(Title of Class of Securities)
028910107
_________________________________________________________________
(CUSIP_Number)
________________________
<PAGE>
CUSIP No. 028910107 Page 2 of 8 Pages
_________________________________________________________________
1) Name of Reporting Person Welsh, Carson,
S.S. or I.R.S. Identification Anderson & Stowe
No. of Above Person V, L.P.
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting 6,352,154 shares of
Beneficially Power Common Stock, $.01
Owned by Each par value ("Common
Reporting Person Stock")
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 6,352,154 shares of
tive Power Common Stock
_______________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 6,352,154 shares of
Owned by Each Reporting Person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 22.4%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 028910107 Page 3 of 8 Pages
_________________________________________________________________
1) Name of Reporting Person WCAS Healthcare
S.S. or I.R.S. Identification Partners, L.P.
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place Delaware
of Organization
_________________________________________________________________
Number of Shares 5) Sole Voting 143,950 shares
Beneficially Power of Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
________________________________________
7) Sole Disposi- 143,950 shares
tive Power of Common Stock
_______________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 143,950 shares
Owned by Each Reporting Person of Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 0.5%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 028910107 Page 4 of 8 Pages
Amendment No. 1 to Schedule 13G
_______________________________
Reference is hereby made to the statement on Schedule 13G
originally filed with the Securities and Exchange Commission on January 29,
1996.
Item 1(a) - Name of Issuer: American Oncology Resources, Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
17001 Northchase Drive, Suite 330
Houston, TX 77060
Item 2(a) - Name of Person Filing:
This statement is being filed by Welsh, Carson, Anderson &
Stowe V, L.P., a Delaware limited partnership ("WCAS V"),
and WCAS Healthcare Partners, L.P., a Delaware limited
partnership ("Healthcare Partners") (collectively, the
"Reporting Persons").
Item 2(b) - Address of Principal Business Office:
320 Park Avenue, Suite 2500
New York, New York 10022
Item 2(c) - Place of Organization:
WCAS V: Delaware
Healthcare Partners: Delaware
Item 2(d) - Title of Class of Securities:
Common Stock, $.01 par value ("Common Stock")
Item 2(e) - CUSIP Number: 028910107
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
Not applicable.
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS V: 6,352,154 shares of Common Stock
Healthcare Partners: 143,950 shares of Common Stock
<PAGE>
CUSIP No. 028910107 Page 5 of 8 Pages
(b) Percent of Class:
WCAS V: 22.4%
Healthcare Partners: 0.5%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: WCAS V:
6,352,154
Healthcare Partners: 143,950
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the
disposition of:
WCAS V: 6,352,154
Healthcare Partners: 143,950
(iv) shared power to dispose or to direct the disposition
of: -0-
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 - Ownership of More than Five Percent on Behalf of Another
Person:
Not applicable.
Item 7 - Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Company:
Not applicable.
Item 8 - Identification and Classification of Members of the Group:
See Exhibit 2.
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
<PAGE>
CUSIP No. 028910107 Page 6 of 8 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
WELSH, CARSON, ANDERSON & STOWE V, L.P.
By: WCAS V Partners, General Partner
By /s/ Laura VanBuren
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Russell L. Carson
General Partner
Dated: January 21, 1997
<PAGE>
CUSIP No. 028910107 Page 7 of 8 Pages
EXHIBIT 1
AGREEMENT
OF
WELSH, CARSON, ANDERSON & STOWE V, L.P.
AND
WCAS HEALTHCARE PARTNERS, L.P.
PURSUANT TO RULE 13d-1(f)
_________________________
The undersigned hereby agree that the Information Statement on
Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on
behalf of each of them in accordance with the provisions of Rule 13d-1(f)
under the Securities Exchange Act of 1934, as amended.
WELSH, CARSON, ANDERSON & STOWE V, L.P.
By: WCAS V Partners, General Partner
By /s/ Laura VanBuren
General Partner
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Russell l. Carson
General Partner
Dated: January 21, 1997
<PAGE>
CUSIP No. 028910107 Page 8 of 8 Pages
EXHIBIT 2
Identification and Classification
of Members of the Group
_________________________________
Welsh, Carson, Anderson & Stowe V, L.P. and WCAS Healthcare
Partners, L.P. are filing this statement on Schedule 13G as a group.
Welsh, Carson, Anderson & Stowe V, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS V Partners, a New Jersey
general partnership.
WCAS Healthcare Partners, L.P. is a Delaware limited partnership.
Its sole general partner is WCAS HP Partners, a Delaware
general partnership.
